NRAS and melanoma: Table 1 shows the clinical and histopathological features according to mutational status in selected genes: BRAF mutation was reported in 25 cases (45.5%), NRAS in 12 cases (21.8%), and mutation in cell cycle genes in 20 cases (36.4%); 12 melanomas were wild type (WT) for all genes in the panel.